ATE409176T1 - 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen - Google Patents
1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungenInfo
- Publication number
- ATE409176T1 ATE409176T1 AT04712483T AT04712483T ATE409176T1 AT E409176 T1 ATE409176 T1 AT E409176T1 AT 04712483 T AT04712483 T AT 04712483T AT 04712483 T AT04712483 T AT 04712483T AT E409176 T1 ATE409176 T1 AT E409176T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- acid derivatives
- neurodegenerative diseases
- phenylalkanecarboxylic acid
- phenylalkanecarboxylic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/12—Polycyclic non-condensed hydrocarbons
- C07C15/14—Polycyclic non-condensed hydrocarbons all phenyl groups being directly linked
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/62—Halogen-containing esters
- C07C69/65—Halogen-containing esters of unsaturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/62—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/40—Unsaturated compounds containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20030311 ITMI20030311A1 (it) | 2003-02-21 | 2003-02-21 | Acidi 2-fenil-2-dialchil-acetici per il trattamento della malattia di alzheimer. |
| ITMI20032068 ITMI20032068A1 (it) | 2003-10-23 | 2003-10-23 | Derivati dell'acido 1-fenilcicloalcancarbossilico per il trattamento delle malattie neurodegenerative. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE409176T1 true ATE409176T1 (de) | 2008-10-15 |
Family
ID=32910543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04712483T ATE409176T1 (de) | 2003-02-21 | 2004-02-19 | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7662995B2 (de) |
| EP (1) | EP1594833B1 (de) |
| JP (1) | JP4472691B2 (de) |
| KR (2) | KR101088272B1 (de) |
| AT (1) | ATE409176T1 (de) |
| AU (1) | AU2004213145B2 (de) |
| BR (1) | BRPI0407662B8 (de) |
| CA (1) | CA2514384C (de) |
| CY (1) | CY1108514T1 (de) |
| DE (1) | DE602004016729D1 (de) |
| DK (1) | DK1594833T3 (de) |
| ES (1) | ES2312964T3 (de) |
| NO (1) | NO333118B1 (de) |
| PT (1) | PT1594833E (de) |
| SI (1) | SI1594833T1 (de) |
| WO (1) | WO2004074232A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| PT1594833E (pt) * | 2003-02-21 | 2008-12-03 | Chiesi Farma Spa | Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas |
| AU2004311577A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
| US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
| US20050252144A1 (en) * | 2004-04-29 | 2005-11-17 | Macdonald Robert A | Veneers for walls, retaining walls and the like |
| PL1778623T3 (pl) | 2004-08-03 | 2008-12-31 | Chiesi Farm Spa | Pochodne kwasów 1-fenyloalkanokarboksylowych do leczenia chorób neurodegeneracyjnych |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020853A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| NZ564789A (en) * | 2005-07-22 | 2010-07-30 | Myriad Genetics Inc | High drug load formulations and dosage forms |
| EP2046119A2 (de) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Behandlung von psychiatrischen störungen |
| JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| WO2009086277A1 (en) | 2007-12-20 | 2009-07-09 | Envivo Pharmaceuticals, Inc. | Tetrasubstituted benzenes |
| EP2133322A1 (de) * | 2008-06-11 | 2009-12-16 | CHIESI FARMACEUTICI S.p.A. | Verfahren zur Herstellung von Derivaten aus 1-(2-Halobiphenyl-4-yl)-Cyclopopancarboxy-Säure |
| JP5996428B2 (ja) * | 2009-08-04 | 2016-09-21 | シエシー ファルマセウティチィ ソシエタ ペル アチオニ | １−（２−ハロビフェニル−４−イル）−シクロプロパンカルボン酸の誘導体の調製方法 |
| WO2011097233A1 (en) | 2010-02-03 | 2011-08-11 | Infinity Pharmaceuticals, Inc. | Fatty acid amide hydrolase inhibitors |
| CN106431900A (zh) | 2010-04-01 | 2017-02-22 | 奇斯药制品公司 | 新的多晶型物和盐 |
| BR112012026803A2 (pt) * | 2010-04-21 | 2016-07-12 | Chiesi Farma Spa | composto |
| WO2011151330A1 (en) | 2010-06-04 | 2011-12-08 | Chiesi Farmaceutici S.P.A. | 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases |
| US9592210B2 (en) | 2011-12-22 | 2017-03-14 | Chiesi Farmaceutici S.P.A. | 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment |
| WO2013150072A1 (en) | 2012-04-04 | 2013-10-10 | Chiesi Farmaceutici S.P.A. | Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| TR201809263T4 (tr) | 2013-06-24 | 2018-07-23 | Chiesi Farm Spa | 1-(2-floro[1,1'-bi̇feni̇l]-4-yl)-si̇klopropankarboksi̇li̇k asi̇t türevleri̇ni̇n hazirlanmasi i̇çi̇n i̇yi̇leşti̇ri̇lmi̇ş proses |
| EP2818460A1 (de) | 2013-06-24 | 2014-12-31 | ZaCh System S.p.A. | Cyclopropanation von substituierten Phenylacetonitrilen oder Phenylacetaten |
| WO2015109109A1 (en) | 2014-01-15 | 2015-07-23 | Forum Pharmaceuticals Inc. | Fused morpholinopyrimidines and methods of use thereof |
| US20150320706A1 (en) | 2014-05-12 | 2015-11-12 | Chiesi Farmaceutici S.P.A. | Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapy |
| US20150335596A1 (en) | 2014-05-26 | 2015-11-26 | Chiesi Farmaceutici S.P.A. | 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome |
| US9802927B2 (en) | 2015-06-10 | 2017-10-31 | Denali Therapeutics, Inc. | Oxadiazine compounds and methods of use thereof |
| KR20240054333A (ko) | 2021-08-31 | 2024-04-25 | 세레스파이어 인코포레이티드 | 공결정 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE735385A (de) | 1968-07-04 | 1969-12-01 | ||
| JPS4994680A (de) | 1973-01-22 | 1974-09-09 | ||
| JPS5046669A (de) | 1973-03-28 | 1975-04-25 | ||
| JPS58177977A (ja) | 1982-04-09 | 1983-10-18 | Grelan Pharmaceut Co Ltd | ４−フエニルピラゾ−ル類 |
| AU2936295A (en) * | 1994-07-13 | 1996-02-16 | Taisho Pharmaceutical Co., Ltd. | Thiopheneacetic acid derivative |
| JPH0994680A (ja) * | 1995-07-24 | 1997-04-08 | Toyota Motor Corp | 摩擦圧接装置 |
| US5994379A (en) | 1998-02-13 | 1999-11-30 | Merck Frosst Canada, Inc. | Bisaryl COX-2 inhibiting compounds, compositions and methods of use |
| AU5702201A (en) | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| AU2004206796A1 (en) * | 2003-01-14 | 2004-08-05 | Merck & Co., Inc. | Geminally di-substituted NSAID derivatives as Abeta 42 lowering agents |
| PT1594833E (pt) * | 2003-02-21 | 2008-12-03 | Chiesi Farma Spa | Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas |
| PL1778623T3 (pl) | 2004-08-03 | 2008-12-31 | Chiesi Farm Spa | Pochodne kwasów 1-fenyloalkanokarboksylowych do leczenia chorób neurodegeneracyjnych |
| EP2133322A1 (de) * | 2008-06-11 | 2009-12-16 | CHIESI FARMACEUTICI S.p.A. | Verfahren zur Herstellung von Derivaten aus 1-(2-Halobiphenyl-4-yl)-Cyclopopancarboxy-Säure |
-
2004
- 2004-02-19 PT PT04712483T patent/PT1594833E/pt unknown
- 2004-02-19 EP EP04712483A patent/EP1594833B1/de not_active Expired - Lifetime
- 2004-02-19 SI SI200430900T patent/SI1594833T1/sl unknown
- 2004-02-19 DE DE602004016729T patent/DE602004016729D1/de not_active Expired - Lifetime
- 2004-02-19 KR KR1020057014850A patent/KR101088272B1/ko not_active Expired - Fee Related
- 2004-02-19 ES ES04712483T patent/ES2312964T3/es not_active Expired - Lifetime
- 2004-02-19 JP JP2006501896A patent/JP4472691B2/ja not_active Expired - Lifetime
- 2004-02-19 AU AU2004213145A patent/AU2004213145B2/en not_active Ceased
- 2004-02-19 WO PCT/EP2004/001596 patent/WO2004074232A1/en not_active Ceased
- 2004-02-19 DK DK04712483T patent/DK1594833T3/da active
- 2004-02-19 BR BRPI0407662A patent/BRPI0407662B8/pt not_active IP Right Cessation
- 2004-02-19 AT AT04712483T patent/ATE409176T1/de active
- 2004-02-19 US US10/546,190 patent/US7662995B2/en not_active Expired - Lifetime
- 2004-02-19 KR KR1020117008239A patent/KR101152448B1/ko not_active Expired - Fee Related
- 2004-02-19 CA CA2514384A patent/CA2514384C/en not_active Expired - Fee Related
-
2005
- 2005-08-18 NO NO20053855A patent/NO333118B1/no not_active IP Right Cessation
-
2008
- 2008-11-14 CY CY20081101310T patent/CY1108514T1/el unknown
-
2009
- 2009-12-24 US US12/647,069 patent/US8022250B2/en not_active Expired - Lifetime
-
2011
- 2011-08-08 US US13/204,989 patent/US8314268B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| WO2005004803A3 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| WO2005004802A3 (en) | N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
| WO2004062625A3 (en) | Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease | |
| WO2005032471A3 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
| EP1562897A4 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| WO2005018545A3 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
| UY27993A1 (es) | Derivados de 4-pirrolidino-fenil-bencil eter | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| ATE383853T1 (de) | Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE60326069D1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
| WO2005003103A3 (en) | 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases | |
| CY1110401T1 (el) | Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
| ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
| ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. | |
| DE602004024992D1 (de) | Verwendung von pyrazolopyridinen zur behandlung von kognitiven defiziten | |
| DE60234031D1 (de) | Mittel zur behandlung allergischer augenerkrankungen | |
| WO2007048034A3 (en) | Use of androgens for the treatment of parkinson' s disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1594833 Country of ref document: EP |